GSK Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by GSK Plc, dated May 12, 2023, serves as a transaction notification for the month of May 2023. The document discloses share acquisitions by Persons Discharging Managerial Responsibilities (PDMRs) and Persons Closely Associated (PCAs) under the Company's Share Reward Plan.
Key Financial Metrics
The filing does not provide consolidated financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. It is strictly a regulatory disclosure of specific insider transactions.
Material Changes and Transaction Details
On May 11, 2023, multiple executives acquired Ordinary Shares (ISIN: GB00BN7SWP63) on the London Stock Exchange. All transactions were executed at a price of £14.5379 per share. The acquisitions consisted of "partnership shares" and "matching shares" under the Share Reward Plan.
- Ms E Walmsley (CEO): Acquired 18 shares (9 partnership, 9 matching).
- Mr J Ford (SVP, Group General Counsel): Acquired 18 shares (9 partnership, 9 matching).
- Ms S Jackson (SVP, Global Communications): Acquired 18 shares (9 partnership, 9 matching).
- Mr D Jackson (PCA of Ms S Jackson): Acquired 16 shares (8 partnership, 8 matching).
- Mr D Redfern (President, Corporate Development): Acquired 18 shares (9 partnership, 9 matching).
- Mr R Simard (President, Global Supply Chain): Acquired 18 shares (9 partnership, 9 matching).
- Mr P Thomson (President, Global Affairs): Acquired 18 shares (9 partnership, 9 matching).
- Ms D Waterhouse (CEO, ViiV Healthcare): Acquired 16 shares (8 partnership, 8 matching).
- Ms V Whyte (Company Secretary): Acquired 18 shares (9 partnership, 9 matching).
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risk factors, or contingencies. It contains no unusual items beyond the routine execution of the Share Reward Plan.
Investor Verification Checklist
- Verify the total number of shares acquired by each executive against the company's internal cap or plan limits.
- Confirm the market price of GSK shares on May 11, 2023, to ensure the transaction price of £14.5379 aligns with market conditions.
- Review the specific terms of the "Share Reward Plan" to understand the vesting schedule and conditions for the partnership and matching shares.
- Check for any subsequent filings regarding the disposal or vesting of these specific shares.